tiprankstipranks
Labcorp Holdings (MX:LH)
:LH
Mexico Market
LH
Labcorp Holdings
RESEARCH TOOLSreports

Labcorp Holdings (LH) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

LH Analyst Ratings

Strong Buy
8Ratings
Strong Buy
7 Buy
1 Hold
0 Sell
Based on 8 analysts giving stock ratings to
Labcorp
Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LH Stock 12 Month Forecast

Average Price Target

$5,487.77
▲(16.63% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Labcorp Holdings in the last 3 months. The average price target is $5,487.77 with a high forecast of $5,847.95 and a low forecast of $5,077.56. The average price target represents a 16.63% change from the last price of $4,705.14.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4496":"$4,496","4834":"$4,834","5172":"$5,172","5510":"$5,510","5848":"$5,848"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5847.95321798,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$5.85K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5487.771326025715,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$5.49K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5077.5641713,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.08K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4496,4834,5172,5510,5848],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Dec<br/>2025","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4705.14,4793.048709075385,4880.95741815077,4968.866127226154,5056.774836301539,5144.683545376924,5232.592254452307,5320.500963527693,5408.409672603077,5496.318381678461,5584.227090753846,5672.135799829231,5760.044508904615,{"y":5847.95321798,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4705.14,4765.342409694286,4825.544819388572,4885.747229082857,4945.949638777143,5006.152048471429,5066.354458165715,5126.55686786,5186.759277554286,5246.961687248572,5307.164096942858,5367.366506637143,5427.568916331429,{"y":5487.771326025715,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4705.14,4733.788013176923,4762.4360263538465,4791.08403953077,4819.732052707693,4848.380065884616,4877.028079061539,4905.676092238462,4934.324105415385,4962.972118592308,4991.620131769231,5020.268144946154,5048.916158123077,{"y":5077.5641713,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4652.739,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4821.376,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4866.742,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4866.742,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5217.721,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5217.721,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4897.072,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4897.072,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4497.885,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4705.14,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4705.14,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4705.14,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4705.14,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$5,848Average Price Target$5,488Lowest Price Target$5,078
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on MX:LH
Michael Ryskin
Bank of America Securities
Bank of America Securities
$5,245.31→$5,594.99
Buy
18.91%
Upside
Reiterated
07/13/26
Labcorp Holdings (LH) Gets a Buy from Bank of America Securities
Argus Research Analyst forecast on MX:LH
David Toung
Argus Research
Argus Research
$5,420.15
Buy
15.20%
Upside
Reiterated
06/02/26
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH), Moderna (NASDAQ: MRNA) and Celcuity (NASDAQ: CELC)
Mizuho Securities Analyst forecast on MX:LH
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
$5,594.99
Buy
18.91%
Upside
Reiterated
05/27/26
Labcorp Holdings (LH) Gets a Buy from Mizuho Securities
Truist Financial Analyst forecast on MX:LH
David S Macdonald
Truist Financial
Truist Financial
$5,594.99
Buy
18.91%
Upside
Reiterated
05/04/26
Analysts' Top Healthcare Picks: BrightSpring Health Services, Inc. (BTSG), Labcorp Holdings (LH)
Robert W. Baird Analyst forecast on MX:LH
Eric Coldwell
Robert W. Baird
Robert W. Baird
$5,804.8→$5,839.77
Buy
24.11%
Upside
Reiterated
05/01/26
Labcorp price target raised to $334 from $332 at BairdLabcorp price target raised to $334 from $332 at Baird
Barclays Analyst forecast on MX:LH
Luke Sergott
Barclays
Barclays
$5,070.46
Hold
7.76%
Upside
Assigned
05/01/26
Labcorp Holdings (LH) Gets a Hold from Barclays
Evercore ISI Analyst forecast on MX:LH
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$5,245.31
Buy
11.48%
Upside
Reiterated
05/01/26
Evercore ISI Keeps Their Buy Rating on Labcorp Holdings (LH)
William Blair Analyst forecast on MX:LH
Andrew Brackmann
William Blair
William Blair
―
Buy
―
Reiterated
04/30/26
Analysts' Top Healthcare Picks: Ionis Pharmaceuticals (IONS), Teladoc (TDOC)
Piper Sandler Analyst forecast on MX:LH
David Westenberg
Piper Sandler
Piper Sandler
$4,720.77→$5,245.31
Hold
11.48%
Upside
Reiterated
02/24/26
Labcorp Holdings (LH) Receives a Hold from Piper Sandler
Morgan Stanley Analyst forecast on MX:LH
Erin Wright
Morgan Stanley
Morgan Stanley
$5,385.18
Buy
14.45%
Upside
Reiterated
02/18/26
Analysts Conflicted on These Healthcare Names: Baxter International (NYSE: BAX), Labcorp Holdings (NYSE: LH) and Vertex Pharmaceuticals (NASDAQ: VRTX)
J.P. Morgan Analyst forecast on MX:LH
Lisa Gill
J.P. Morgan
J.P. Morgan
$5,577.51→$5,769.84
Buy
22.63%
Upside
Reiterated
02/18/26
Labcorp price target raised to $330 from $319 at JPMorganLabcorp price target raised to $330 from $319 at JPMorgan
Citi Analyst forecast on MX:LH
Patrick B Donnelly
Citi
Citi
$5,682.41
Buy
20.77%
Upside
Reiterated
01/02/26
Analysts' Top Healthcare Picks: Doximity (DOCS), Labcorp Holdings (LH)
UBS Analyst forecast on MX:LH
Kevin Caliendo
UBS
UBS
$5,682.41→$5,594.99
Buy
18.91%
Upside
Reiterated
10/29/25
Labcorp price target lowered to $320 from $325 at UBSLabcorp price target lowered to $320 from $325 at UBS
Leerink Partners Analyst forecast on MX:LH
Michael Cherny
Leerink Partners
Leerink Partners
$5,647.45→$5,979.65
Buy
27.09%
Upside
Reiterated
10/08/25
Leerink Partners Reaffirms Their Buy Rating on Labcorp Holdings (LH)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on MX:LH
Michael Ryskin
Bank of America Securities
Bank of America Securities
$5,245.31→$5,594.99
Buy
18.91%
Upside
Reiterated
07/13/26
Labcorp Holdings (LH) Gets a Buy from Bank of America Securities
Argus Research Analyst forecast on MX:LH
David Toung
Argus Research
Argus Research
$5,420.15
Buy
15.20%
Upside
Reiterated
06/02/26
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH), Moderna (NASDAQ: MRNA) and Celcuity (NASDAQ: CELC)
Mizuho Securities Analyst forecast on MX:LH
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
$5,594.99
Buy
18.91%
Upside
Reiterated
05/27/26
Labcorp Holdings (LH) Gets a Buy from Mizuho Securities
Truist Financial Analyst forecast on MX:LH
David S Macdonald
Truist Financial
Truist Financial
$5,594.99
Buy
18.91%
Upside
Reiterated
05/04/26
Analysts' Top Healthcare Picks: BrightSpring Health Services, Inc. (BTSG), Labcorp Holdings (LH)
Robert W. Baird Analyst forecast on MX:LH
Eric Coldwell
Robert W. Baird
Robert W. Baird
$5,804.8→$5,839.77
Buy
24.11%
Upside
Reiterated
05/01/26
Labcorp price target raised to $334 from $332 at BairdLabcorp price target raised to $334 from $332 at Baird
Barclays Analyst forecast on MX:LH
Luke Sergott
Barclays
Barclays
$5,070.46
Hold
7.76%
Upside
Assigned
05/01/26
Labcorp Holdings (LH) Gets a Hold from Barclays
Evercore ISI Analyst forecast on MX:LH
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$5,245.31
Buy
11.48%
Upside
Reiterated
05/01/26
Evercore ISI Keeps Their Buy Rating on Labcorp Holdings (LH)
William Blair Analyst forecast on MX:LH
Andrew Brackmann
William Blair
William Blair
―
Buy
―
Reiterated
04/30/26
Analysts' Top Healthcare Picks: Ionis Pharmaceuticals (IONS), Teladoc (TDOC)
Piper Sandler Analyst forecast on MX:LH
David Westenberg
Piper Sandler
Piper Sandler
$4,720.77→$5,245.31
Hold
11.48%
Upside
Reiterated
02/24/26
Labcorp Holdings (LH) Receives a Hold from Piper Sandler
Morgan Stanley Analyst forecast on MX:LH
Erin Wright
Morgan Stanley
Morgan Stanley
$5,385.18
Buy
14.45%
Upside
Reiterated
02/18/26
Analysts Conflicted on These Healthcare Names: Baxter International (NYSE: BAX), Labcorp Holdings (NYSE: LH) and Vertex Pharmaceuticals (NASDAQ: VRTX)
J.P. Morgan Analyst forecast on MX:LH
Lisa Gill
J.P. Morgan
J.P. Morgan
$5,577.51→$5,769.84
Buy
22.63%
Upside
Reiterated
02/18/26
Labcorp price target raised to $330 from $319 at JPMorganLabcorp price target raised to $330 from $319 at JPMorgan
Citi Analyst forecast on MX:LH
Patrick B Donnelly
Citi
Citi
$5,682.41
Buy
20.77%
Upside
Reiterated
01/02/26
Analysts' Top Healthcare Picks: Doximity (DOCS), Labcorp Holdings (LH)
UBS Analyst forecast on MX:LH
Kevin Caliendo
UBS
UBS
$5,682.41→$5,594.99
Buy
18.91%
Upside
Reiterated
10/29/25
Labcorp price target lowered to $320 from $325 at UBSLabcorp price target lowered to $320 from $325 at UBS
Leerink Partners Analyst forecast on MX:LH
Michael Cherny
Leerink Partners
Leerink Partners
$5,647.45→$5,979.65
Buy
27.09%
Upside
Reiterated
10/08/25
Leerink Partners Reaffirms Their Buy Rating on Labcorp Holdings (LH)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Labcorp Holdings

3 Months
Erin WrightMorgan Stanley
Success Rate
16/22 ratings generated profit
73%
Average Return
+5.23%
reiterated a buy rating 5 months ago
Copying Erin Wright's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +5.23% per trade.
1 Year
Lisa GillJ.P. Morgan
Success Rate
12/12 ratings generated profit
100%
Average Return
+17.32%
reiterated a buy rating 5 months ago
Copying Lisa Gill's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +17.32% per trade.
2 Years
Erin WrightMorgan Stanley
Success Rate
22/22 ratings generated profit
100%
Average Return
+28.16%
reiterated a buy rating 5 months ago
Copying Erin Wright's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +28.16% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LH Analyst Recommendation Trends

Rating
Feb 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
26
27
25
15
21
Hold
14
23
22
17
14
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
40
50
47
32
35
In the current month, LH has received 21 Buy Ratings, 14 Hold Ratings, and 0 Sell Ratings. LH average Analyst price target in the past 3 months is 5,487.77.
Each month's total comprises the sum of three months' worth of ratings.

LH Financial Forecast

LH Earnings Forecast

Next quarter’s earnings estimate for LH is $83.32 with a range of $81.59 to $87.52. The previous quarter’s EPS was $74.09. LH beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 48.00% of the time in the same period. In the last calendar year LH has Outperformed its overall industry.
Next quarter’s earnings estimate for LH is $83.32 with a range of $81.59 to $87.52. The previous quarter’s EPS was $74.09. LH beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 48.00% of the time in the same period. In the last calendar year LH has Outperformed its overall industry.

LH Sales Forecast

Next quarter’s sales forecast for LH is $64.67B with a range of $64.16B to $65.15B. The previous quarter’s sales results were $61.67B. LH beat its sales estimates 66.67% of the time in past 12 months, while its overall industry beat sales estimates 55.41% of the time in the same period. In the last calendar year LH has Outperformed its overall industry.
Next quarter’s sales forecast for LH is $64.67B with a range of $64.16B to $65.15B. The previous quarter’s sales results were $61.67B. LH beat its sales estimates 66.67% of the time in past 12 months, while its overall industry beat sales estimates 55.41% of the time in the same period. In the last calendar year LH has Outperformed its overall industry.

LH Stock Forecast FAQ

What is MX:LH’s average 12-month price target, according to analysts?
Based on analyst ratings, Labcorp Holdings’s 12-month average price target is 5,487.77.
    What is MX:LH’s upside potential, based on the analysts’ average price target?
    Labcorp Holdings has 16.63% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Labcorp Holdings a Buy, Sell or Hold?
          Labcorp Holdings has a consensus rating of Strong Buy, which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Labcorp Holdings’s share price target?
            The average share price target for Labcorp Holdings is 5,487.77. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $5,847.95 ,and the lowest forecast is $5,077.56. The average share price target represents 16.63% Increase from the current price of $4,705.14.
              What do analysts say about Labcorp Holdings?
              Labcorp Holdings’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of Labcorp Holdings?
                To buy shares of MX:LH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.